Cargando…

Suppression of experimental cerebral malaria by disruption of malate:quinone oxidoreductase

BACKGROUND: Aspartate, which is converted from oxaloacetate (OAA) by aspartate aminotransferase, is considered an important precursor for purine salvage and pyrimidine de novo biosynthesis, and is thus indispensable for the growth of Plasmodium parasites at the asexual blood stages. OAA can be produ...

Descripción completa

Detalles Bibliográficos
Autores principales: Niikura, Mamoru, Komatsuya, Keisuke, Inoue, Shin-Ichi, Matsuda, Risa, Asahi, Hiroko, Inaoka, Daniel Ken, Kita, Kiyoshi, Kobayashi, Fumie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469008/
https://www.ncbi.nlm.nih.gov/pubmed/28606087
http://dx.doi.org/10.1186/s12936-017-1898-5
_version_ 1783243501721354240
author Niikura, Mamoru
Komatsuya, Keisuke
Inoue, Shin-Ichi
Matsuda, Risa
Asahi, Hiroko
Inaoka, Daniel Ken
Kita, Kiyoshi
Kobayashi, Fumie
author_facet Niikura, Mamoru
Komatsuya, Keisuke
Inoue, Shin-Ichi
Matsuda, Risa
Asahi, Hiroko
Inaoka, Daniel Ken
Kita, Kiyoshi
Kobayashi, Fumie
author_sort Niikura, Mamoru
collection PubMed
description BACKGROUND: Aspartate, which is converted from oxaloacetate (OAA) by aspartate aminotransferase, is considered an important precursor for purine salvage and pyrimidine de novo biosynthesis, and is thus indispensable for the growth of Plasmodium parasites at the asexual blood stages. OAA can be produced in malaria parasites via two routes: (i) from phosphoenolpyruvate (PEP) by phosphoenolpyruvate carboxylase (PEPC) in the cytosol, or (ii) from fumarate by consecutive reactions catalyzed by fumarate hydratase (FH) and malate:quinone oxidoreductase (MQO) in the mitochondria of malaria parasites. Although PEPC-deficient Plasmodium falciparum and Plasmodium berghei (rodent malaria) parasites show a growth defect, the mutant P. berghei can still cause experimental cerebral malaria (ECM) with similar dynamics to wild-type parasites. In contrast, the importance of FH and MQO for parasite viability, growth and virulence is not fully understood because no FH- and MQO-deficient P. falciparum has been established. In this study, the role of FH and MQO in the pathogenicity of asexual-blood-stage Plasmodium parasites causing cerebral malaria was examined. RESULTS: First, FH- and MQO-deficient parasites were generated by inserting a luciferase-expressing cassette into the fh and mqo loci in the genome of P. berghei ANKA strain. Second, the viability of FH-deficient and MQO-deficient parasites that express luciferase was determined by measuring luciferase activity, and the effect of FH or MQO deficiency on the development of ECM was examined. While the viability of FH-deficient P. berghei was comparable to that of control parasites, MQO-deficient parasites exhibited considerably reduced viability. FH activity derived from erythrocytes was also detected. This result and the absence of phenotype in FH-deficient P. berghei parasites suggest that fumarate can be metabolized to malate by host or parasite FH in P. berghei-infected erythrocytes. Furthermore, although the growth of FH- and MQO-deficient parasites was impaired, the development of ECM was suppressed only in mice infected with MQO-deficient parasites. CONCLUSIONS: These findings suggest that MQO-mediated mitochondrial functions are required for development of ECM of asexual-blood-stage Plasmodium parasites. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12936-017-1898-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5469008
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54690082017-06-14 Suppression of experimental cerebral malaria by disruption of malate:quinone oxidoreductase Niikura, Mamoru Komatsuya, Keisuke Inoue, Shin-Ichi Matsuda, Risa Asahi, Hiroko Inaoka, Daniel Ken Kita, Kiyoshi Kobayashi, Fumie Malar J Research BACKGROUND: Aspartate, which is converted from oxaloacetate (OAA) by aspartate aminotransferase, is considered an important precursor for purine salvage and pyrimidine de novo biosynthesis, and is thus indispensable for the growth of Plasmodium parasites at the asexual blood stages. OAA can be produced in malaria parasites via two routes: (i) from phosphoenolpyruvate (PEP) by phosphoenolpyruvate carboxylase (PEPC) in the cytosol, or (ii) from fumarate by consecutive reactions catalyzed by fumarate hydratase (FH) and malate:quinone oxidoreductase (MQO) in the mitochondria of malaria parasites. Although PEPC-deficient Plasmodium falciparum and Plasmodium berghei (rodent malaria) parasites show a growth defect, the mutant P. berghei can still cause experimental cerebral malaria (ECM) with similar dynamics to wild-type parasites. In contrast, the importance of FH and MQO for parasite viability, growth and virulence is not fully understood because no FH- and MQO-deficient P. falciparum has been established. In this study, the role of FH and MQO in the pathogenicity of asexual-blood-stage Plasmodium parasites causing cerebral malaria was examined. RESULTS: First, FH- and MQO-deficient parasites were generated by inserting a luciferase-expressing cassette into the fh and mqo loci in the genome of P. berghei ANKA strain. Second, the viability of FH-deficient and MQO-deficient parasites that express luciferase was determined by measuring luciferase activity, and the effect of FH or MQO deficiency on the development of ECM was examined. While the viability of FH-deficient P. berghei was comparable to that of control parasites, MQO-deficient parasites exhibited considerably reduced viability. FH activity derived from erythrocytes was also detected. This result and the absence of phenotype in FH-deficient P. berghei parasites suggest that fumarate can be metabolized to malate by host or parasite FH in P. berghei-infected erythrocytes. Furthermore, although the growth of FH- and MQO-deficient parasites was impaired, the development of ECM was suppressed only in mice infected with MQO-deficient parasites. CONCLUSIONS: These findings suggest that MQO-mediated mitochondrial functions are required for development of ECM of asexual-blood-stage Plasmodium parasites. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12936-017-1898-5) contains supplementary material, which is available to authorized users. BioMed Central 2017-06-12 /pmc/articles/PMC5469008/ /pubmed/28606087 http://dx.doi.org/10.1186/s12936-017-1898-5 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Niikura, Mamoru
Komatsuya, Keisuke
Inoue, Shin-Ichi
Matsuda, Risa
Asahi, Hiroko
Inaoka, Daniel Ken
Kita, Kiyoshi
Kobayashi, Fumie
Suppression of experimental cerebral malaria by disruption of malate:quinone oxidoreductase
title Suppression of experimental cerebral malaria by disruption of malate:quinone oxidoreductase
title_full Suppression of experimental cerebral malaria by disruption of malate:quinone oxidoreductase
title_fullStr Suppression of experimental cerebral malaria by disruption of malate:quinone oxidoreductase
title_full_unstemmed Suppression of experimental cerebral malaria by disruption of malate:quinone oxidoreductase
title_short Suppression of experimental cerebral malaria by disruption of malate:quinone oxidoreductase
title_sort suppression of experimental cerebral malaria by disruption of malate:quinone oxidoreductase
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469008/
https://www.ncbi.nlm.nih.gov/pubmed/28606087
http://dx.doi.org/10.1186/s12936-017-1898-5
work_keys_str_mv AT niikuramamoru suppressionofexperimentalcerebralmalariabydisruptionofmalatequinoneoxidoreductase
AT komatsuyakeisuke suppressionofexperimentalcerebralmalariabydisruptionofmalatequinoneoxidoreductase
AT inoueshinichi suppressionofexperimentalcerebralmalariabydisruptionofmalatequinoneoxidoreductase
AT matsudarisa suppressionofexperimentalcerebralmalariabydisruptionofmalatequinoneoxidoreductase
AT asahihiroko suppressionofexperimentalcerebralmalariabydisruptionofmalatequinoneoxidoreductase
AT inaokadanielken suppressionofexperimentalcerebralmalariabydisruptionofmalatequinoneoxidoreductase
AT kitakiyoshi suppressionofexperimentalcerebralmalariabydisruptionofmalatequinoneoxidoreductase
AT kobayashifumie suppressionofexperimentalcerebralmalariabydisruptionofmalatequinoneoxidoreductase